Evidence map›Paper›PMID 19934016›Full record

ArticleDevelopment (Cambridge, England)2009

Neuropeptide Y functions as a facilitator of GDNF-induced budding of the Wolffian duct.

Yohan Choi, James B Tee, Thomas F Gallegos, Mita M Shah, Hideto Oishi, Hiroyuki Sakurai, Shinji Kitamura, Wei Wu, Kevin T Bush, Sanjay K Nigam

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Gene regulatory network of renal primordium development.Pediatric nephrology (Berlin, Germany) · 2014
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yohan ChoiDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0693, USA.
James B Tee
Thomas F Gallegos
Mita M Shah
Hideto Oishi
Hiroyuki Sakurai
Shinji Kitamura
Wei Wu
Kevin T Bush
Sanjay K Nigam
University of California, San Diego · USUniversity of Calgary · CA

Funding

HYPERTENTIONT32HL007261 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI THOMSON, SCOTT CULVER · 1985 to 2015
$4.9M
FACTORS MEDIATING URETERIC MIGRATION AND MORPHOGENESISR01DK057286 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIGAM, SANJAY K · 2000 to 2010
$3.7M
Identification of Genes Regulating Ureter MorphogenesisR01DK065831 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIGAM, SANJAY K · 2004 to 2007
$1.5M
NHLBI NIH HHS T-32 HL007261NHLBI NIH HHS T32 HL007261NIDDK NIH HHS R01 DK057286NIDDK NIH HHS R01 DK065831NIDDK NIH HHS R01-DK57286NIDDK NIH HHS R01-DK65831
6 · The paper itself

Abstract

Ureteric bud (UB) emergence from the Wolffian duct (WD), the initiating step in metanephric kidney morphogenesis, is dependent on GDNF; however, GDNF by itself is generally insufficient to induce robust budding of the isolated WD in culture. Thus, additional factors, presumably peptides or polypeptide growth factors, might be involved. Microarray data from in vivo budding and non-budding conditions were analyzed using non-negative matrix factorization followed by gene ontology filtering and network analysis to identify sets of genes that are highly regulated during budding. These included the GDNF co-receptors GFRalpha1 and RET, as well as neuropeptide Y (NPY). By using ANOVA with pattern matching, NPY was also found to correlate most significantly to the budded condition with a high degree of connectedness to genes with developmental roles. Exogenous NPY [as well as its homolog, peptide YY (PYY)] augmented GDNF-dependent budding in the isolated WD culture; conversely, inhibition of NPY signaling or perturbation of NPY expression inhibited budding, confirming that NPY facilitates this process. NPY was also found to reverse the decreased budding, the downregulation of RET expression, the mislocalization of GFRalpha1, and the inhibition of AKT phosphorylation that resulted from the addition of BMP4 to the isolated WD cultures, suggesting that NPY acts through the budding pathway and is reciprocally regulated by GDNF and BMP4. Thus, the outgrowth of the UB from the WD might result from a combination of the upregulation of the GDNF receptors together with genes that support GDNF signaling in a feed-forward loop and/or counteraction of the inhibitory pathway regulated by BMP4.

Indexed as

AnimalsBone Morphogenetic Protein 4Cells, CulturedFemaleGene Expression Regulation, DevelopmentalGlial Cell Line-Derived Neurotrophic Factor ReceptorsMorphogenesisNeuropeptide YOligonucleotide Array Sequence AnalysisProto-Oncogene Proteins c-retRatsRats, Sprague-DawleySignal TransductionUp-RegulationWolffian DuctsBone Morphogenetic Protein 4Glial Cell Line-Derived Neurotrophic Factor ReceptorsNeuropeptide YProto-Oncogene Proteins c-ret

Identifiers

PMID19934016
PMCPMC2781055
OpenAlexW2078977432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.